Literature DB >> 19373694

The effects of intravitreal ophthalmic medications on intraocular pressure.

Huijuan Wu1, Teresa C Chen.   

Abstract

Ophthalmic medications are often given as intravitreal injection. Antimicrobials, antivirals, corticosteroids and anti- vascular endothelial growth factor agents are the main classes which can be administered through intravitreal injections. Possible complications of intravitreal injection include intraocular pressure changes, especially intraocular pressure elevations. This review discusses both injection-related intraocular pressure elevations which can occur immediately after injection of any kind of medication and drug specific-related intraocular pressure changes which may be detected days or even months after the injection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19373694     DOI: 10.1080/08820530902800397

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  7 in total

1.  Immediate intraocular pressure rise after intravitreal injection of ranibizumab and two doses of triamcinolone acetonide.

Authors:  Gul Arikan; Ali Osman Saatci; Ferit Hakan Oner
Journal:  Int J Ophthalmol       Date:  2011-08-18       Impact factor: 1.779

2.  Anterior segment changes on ultrasound biomicroscopy after intravitreal anti vascular endothelial growth factor injection.

Authors:  H S Trehan; Jaya Kaushik; Atul Rangi; A S Parihar; P Vashisht; J K S Parihar
Journal:  Med J Armed Forces India       Date:  2016-12-01

3.  Intravitreal injection of bevacizumab: changes in intraocular pressure related to ocular axial length.

Authors:  Andrea Cacciamani; Francesco Oddone; Mariacristina Parravano; Fabio Scarinci; Marta Di Nicola; Giorgio Lofoco
Journal:  Jpn J Ophthalmol       Date:  2012-10-24       Impact factor: 2.447

4.  The effect of ocular pigmentation on transscleral delivery of triamcinolone acetonide.

Authors:  Wennan Du; Shumao Sun; Yu Xu; Jie Li; Chunhui Zhao; Bifei Lan; Hao Chen; Lingyun Cheng
Journal:  J Ocul Pharmacol Ther       Date:  2013-04-18       Impact factor: 2.671

5.  Oral delivery of ACE2/Ang-(1-7) bioencapsulated in plant cells protects against experimental uveitis and autoimmune uveoretinitis.

Authors:  Pollob K Shil; Kwang-Chul Kwon; Ping Zhu; Amrisha Verma; Henry Daniell; Qiuhong Li
Journal:  Mol Ther       Date:  2014-09-17       Impact factor: 11.454

Review 6.  Gene therapy for ocular diseases meditated by ultrasound and microbubbles (Review).

Authors:  Caifeng Wan; Fenghua Li; Hongli Li
Journal:  Mol Med Rep       Date:  2015-07-07       Impact factor: 2.952

7.  Targeted and reversible blood-retinal barrier disruption via focused ultrasound and microbubbles.

Authors:  Juyoung Park; Yongzhi Zhang; Natalia Vykhodtseva; James D Akula; Nathan J McDannold
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.